Capstone Holding Corp. Files 8-K: Material Agreement & Exhibits
Ticker: CAPS · Form: 8-K · Filed: Nov 28, 2025 · CIK: 887151
Sentiment: neutral
Topics: material-agreement, filing, corporate-actions
Related Tickers: CAPS
TL;DR
CAPSTONE HOLDING CORP. (CAPS) filed an 8-K on 11/28/25 for a material definitive agreement. Check for details.
AI Summary
On November 28, 2025, Capstone Holding Corp. filed an 8-K report. The filing indicates an entry into a material definitive agreement and includes financial statements and exhibits. The company, formerly known as Capstone Therapeutics Corp. and Orthologic Corp., is incorporated in Delaware and headquartered in Alsip, Illinois.
Why It Matters
This 8-K filing signals a significant development for Capstone Holding Corp., potentially involving a new material agreement that could impact its business operations and financial standing.
Risk Assessment
Risk Level: medium — An 8-K filing for a material definitive agreement can introduce new risks or opportunities that are not yet fully understood by the market.
Key Numbers
- 001-33560 — Commission File Number (SEC filing identifier for Capstone Holding Corp.)
- 86-0585310 — I.R.S. Employer Identification No. (Tax identification number for Capstone Holding Corp.)
Key Players & Entities
- Capstone Holding Corp. (company) — Registrant
- November 28, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- Alsip, IL (location) — Principal executive offices
- Capstone Therapeutics Corp. (company) — Former company name
- Orthologic Corp (company) — Former company name
FAQ
What is the nature of the material definitive agreement entered into by Capstone Holding Corp. on November 28, 2025?
The filing indicates an 'Entry into a Material Definitive Agreement' as an item of disclosure, but the specific details of the agreement are not provided in this excerpt.
What are the key items reported in this 8-K filing by Capstone Holding Corp.?
The key items reported are 'Entry into a Material Definitive Agreement' and 'Financial Statements and Exhibits'.
When was the earliest event reported in this 8-K filing?
The earliest event reported was on November 28, 2025.
What were Capstone Holding Corp.'s previous names?
Capstone Holding Corp. was formerly known as Capstone Therapeutics Corp. and prior to that, Orthologic Corp.
Where is Capstone Holding Corp. headquartered?
Capstone Holding Corp.'s principal executive offices are located at 5141 W. 122nd Street, Alsip, IL 60803.
Filing Stats: 705 words · 3 min read · ~2 pages · Grade level 10.4 · Accepted 2025-11-28 15:10:47
Key Financial Figures
- $0.0005 — ch registered Common Stock, par value $0.0005 per share CAPS The Nasdaq Stock Mar
- $10,909,885 — gate original principal amount of up to $10,909,885, which are being issued with a 8.34% or
- $3,272,966 — ginal principal amount of approximately $3,272,966 (the " July 2025 Convertible Note "), a
- $3,545,712.42 — ginal principal amount of approximately $3,545,712.42 (the " October 2025 Convertible Note ",
- $1.72 — n initial conversion price per share of $1.72 (subsequently reduced to $1.00) and the
- $1.00 — share of $1.72 (subsequently reduced to $1.00) and the October 2025 Convertible Note
- $1.10 — tible Note having a conversion price of $1.10 (the " Conversion Price) ". Pursuant t
- $0.75 — ties, to reduce the Conversion Price to $0.75 with regard to the entire amount of the
- $500,744 — Note still owed in the principal amount $500,744.01, and with regard to $1,772,856.21 of
- $1,772,856.21 — amount $500,744.01, and with regard to $1,772,856.21 of the principal amount of the October
Filing Documents
- ea0267668-8k_capstone.htm (8-K) — 26KB
- ea026766801ex10-1_capstone.htm (EX-10.1) — 12KB
- 0001213900-25-116037.txt ( ) — 205KB
- caps-20251128.xsd (EX-101.SCH) — 3KB
- caps-20251128_lab.xml (EX-101.LAB) — 33KB
- caps-20251128_pre.xml (EX-101.PRE) — 22KB
- ea0267668-8k_capstone_htm.xml (XML) — 4KB
01. Entry into a Material Definitive Agreement
Item 1.01. Entry into a Material Definitive Agreement. As previously disclosed, on July 29, 2025, Capstone Holding Corp. (the " Company ") entered into a securities purchase agreement (the " Purchase Agreement ") with an institutional investor (the " Buyer "), pursuant to which the Company authorized the issuance of senior secured convertible notes to the Buyer, in the aggregate original principal amount of up to $10,909,885, which are being issued with a 8.34% original issue discount (each, a " Convertible Note "). The first Convertible Note was issued in the original principal amount of approximately $3,272,966 (the " July 2025 Convertible Note "), and the second Convertible Note was issued in the original principal amount of approximately $3,545,712.42 (the " October 2025 Convertible Note ", and together with the July 2025 Convertible Note, the " Notes "). The Convertible Notes are convertible into shares of common stock, $0.0005 par value per share (the " Common Stock ") in certain circumstances in accordance with the terms of the Convertible Notes, with the July 2025 Convertible Note having an initial conversion price per share of $1.72 (subsequently reduced to $1.00) and the October 2025 Convertible Note having a conversion price of $1.10 (the " Conversion Price) ". Pursuant to the effective registration statements on Form S-1 (File Nos. 333-289222 and 333-291041), the Company registered a total of 8,388,336 shares of Common Stock issuable upon conversion of the Convertible Notes. On November 28, 2025, pursuant to Section 7(h) of the Notes, the Company and the Buyer agreed, pursuant to a Conversion Price Voluntary Adjustment Notice signed by both parties, to reduce the Conversion Price to $0.75 with regard to the entire amount of the July 2025 Convertible Note still owed in the principal amount $500,744.01, and with regard to $1,772,856.21 of the principal amount of the October 2025 Convertible Note (with $1,772,856.21 of the principal balance of the Octob
01. Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits. (d) Exhibits. Exhibit Number Exhibits 10.1 Conversion Price Voluntary Adjustment Notice 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) 1
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: November 28, 2025 Capstone Holding Corp. By: /s/ Matthew E. Lipman Name: Matthew E. Lipman Title: Chief Executive Officer 2